Dynamic Technology Lab Private Ltd Purchases 2,093 Shares of Stryker Co. (NYSE:SYK)

Dynamic Technology Lab Private Ltd grew its position in Stryker Co. (NYSE:SYK - Free Report) by 238.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,970 shares of the medical technology company's stock after purchasing an additional 2,093 shares during the period. Dynamic Technology Lab Private Ltd's holdings in Stryker were worth $1,069,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in SYK. Vanguard Group Inc. boosted its stake in Stryker by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 32,698,828 shares of the medical technology company's stock valued at $11,773,213,000 after acquiring an additional 252,188 shares during the last quarter. Geode Capital Management LLC grew its stake in Stryker by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 7,073,562 shares of the medical technology company's stock worth $2,539,033,000 after buying an additional 168,436 shares during the last quarter. Norges Bank bought a new stake in Stryker in the 4th quarter valued at about $1,710,744,000. Charles Schwab Investment Management Inc. boosted its position in shares of Stryker by 2.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,985,045 shares of the medical technology company's stock worth $714,715,000 after buying an additional 48,819 shares during the period. Finally, TD Asset Management Inc. grew its holdings in Stryker by 7.0% in the 4th quarter. TD Asset Management Inc. now owns 1,264,686 shares of the medical technology company's stock worth $455,350,000 after buying an additional 82,306 shares in the last quarter. Hedge funds and other institutional investors own 77.09% of the company's stock.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of the business's stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the transaction, the director now owns 3,642,075 shares of the company's stock, valued at approximately $1,428,567,498. The trade was a 5.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the sale, the director now directly owns 14,895 shares in the company, valued at $5,705,827.65. This trade represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Truist Financial raised their price target on Stryker from $409.00 to $413.00 and gave the company a "hold" rating in a report on Thursday, January 30th. The Goldman Sachs Group set a $422.00 price target on shares of Stryker in a research report on Tuesday, March 4th. JMP Securities reiterated a "market perform" rating on shares of Stryker in a research note on Tuesday, February 18th. Wells Fargo & Company upped their target price on Stryker from $427.00 to $435.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 29th. Finally, StockNews.com downgraded Stryker from a "buy" rating to a "hold" rating in a research note on Thursday, March 6th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, Stryker has a consensus rating of "Moderate Buy" and an average target price of $421.90.

Stryker Stock Down 0.7 %

SYK stock traded down $2.35 during midday trading on Friday, reaching $346.04. The company had a trading volume of 572,998 shares, compared to its average volume of 1,351,449. The company has a 50 day moving average of $376.39 and a two-hundred day moving average of $373.61. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The company has a market capitalization of $132.08 billion, a P/E ratio of 44.53, a PEG ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period in the previous year, the business posted $3.46 earnings per share. On average, equities research analysts expect that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Monday, March 31st. Stryker's payout ratio is 43.30%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.